Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal malignant solid tumors.

G Cecchetto1, C Previtera, A Messineo

  • 1Department of Pediatric Surgery, University of Padua, Italy.

Tumori
|February 28, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same journal

End-of-life decisions and opinions: Results of E.L.D.Y.-CA.RE study carried out at Veneto Institute of Oncology, Italy.

Tumori·2026
Same journal

Quality indicators in identification and care of patients with genetic predisposition to cancer: An AIFET proposal.

Tumori·2026
Same journal

Driver vs. passenger: Primary resistance to larotrectinib in synovial sarcoma harboring concurrent SS18 rearrangement and PDE3A-NTRK2 fusion.

Tumori·2026
Same journal

Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC.

Tumori·2026
Same journal

Challenging the cornerstone: Toward risk-adapted follow-up in early breast cancer.

Tumori·2026
Same journal

Assessing in house comprehensive genomic profiling by liquid biopsy for NSCLC patients.

Tumori·2026
See all related articles

Pediatric surgical oncology outcomes for infants with malignant solid tumors show promising survival rates with combined therapies. Early diagnosis and conservative surgical approaches are crucial for successful treatment in neonates.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Neonatal Medicine

Background:

  • Malignant solid tumors are rare in neonates (infants < 1 month).
  • Limited data exists on treatment outcomes for this specific population.
  • Early diagnosis and intervention are critical for improving survival.

Purpose of the Study:

  • To review outcomes of malignant solid tumors in neonates.
  • To evaluate the effectiveness of combined therapeutic approaches.
  • To emphasize the role of conservative surgery in infant cancer treatment.

Main Methods:

  • Retrospective review of 8 neonates with malignant solid tumors.
  • Data collected from the Pediatric Surgical Department of Padua University (1968-1985).
  • Analysis of tumor types, treatment modalities, and patient outcomes.

Related Experiment Videos

Main Results:

  • The study included 6 neuroblastomas, 1 Wilms' tumor, and 1 angiosarcoma.
  • Five out of eight patients (62.5%) survived with no evidence of disease.
  • Median follow-up was 8 years.

Conclusions:

  • Combined therapeutic approaches, including conservative surgery, are vital for treating neonatal malignant solid tumors.
  • Infants exhibit significant sensitivity to chemotherapy and radiotherapy.
  • Surgical resection remains the primary treatment when feasible.